Culture & Sensitivity – Bone Marrow (SHM) at Dr. Essa Lab

Understanding Culture & Sensitivity – Bone Marrow (SHM) at Dr. Essa Lab

The Culture & Sensitivity – Bone Marrow (SHM) is a highly specialized diagnostic laboratory investigation designed to isolate, identify, and analyze pathogenic microorganisms residing within the bone marrow cavity. Unlike routine peripheral blood cultures, a bone marrow culture (often referred to as a myeloculture) offers superior diagnostic sensitivity for specific systemic, intracellular, and deep-seated infectious diseases. The bone marrow is a highly vascularized tissue located within the medullary cavities of bones, serving as the primary site for hematopoiesis and containing a dense concentration of reticuloendothelial cells. Certain pathogens preferentially colonize or are phagocytosed within this microenvironment, making the bone marrow an invaluable diagnostic reservoir when peripheral blood cultures remain negative.

At Dr. Essa Lab, this advanced microbiological analysis is conducted using state-of-the-art automated continuous-monitoring culture systems alongside traditional selective media. The term “SHM” denotes specialized hematology and microbiology protocols tailored to optimize the recovery of fastidious organisms, including slow-growing bacteria, mycobacteria, and fungi. By inoculating bone marrow aspirate into specialized culture media, clinical microbiologists can detect the presence of viable pathogens. Once an organism is isolated, standardized antimicrobial susceptibility testing (AST) is performed to determine the most effective therapeutic agents. This test is critical in guiding targeted antimicrobial therapy, preventing the development of multi-drug resistance, and managing complex, pyrexial illnesses of unknown origin.

Clinical Procedure: What to Expect

Patient Preparation

Because bone marrow aspiration is an invasive medical procedure, meticulous patient preparation is essential to ensure safety, minimize discomfort, and preserve sample integrity. Patients undergoing this procedure at or in coordination with Dr. Essa Lab should adhere to the following clinical guidelines:

• Informed Consent: A detailed explanation of the procedure, including potential risks and benefits, will be provided by the performing clinician, and written informed consent must be obtained.
• Medication Review: Patients must inform their physician of all ongoing medications. Antiplatelet agents (such as aspirin or clopidogrel) and anticoagulants (such as warfarin or low-molecular-weight heparin) may need to be temporarily adjusted or held to minimize the risk of post-procedural bleeding.
• Fasting Guidelines: While standard bone marrow aspiration under local anesthesia does not strictly require fasting, patients undergoing conscious sedation may be instructed to fast (nil per os) for 4 to 6 hours prior to the procedure.
• Antibiotic History: It is critical to document any recent or ongoing antibiotic therapy. Antibiotics can suppress microbial growth in vitro, potentially leading to false-negative culture results. If clinically safe, the procedure may be scheduled prior to initiating antimicrobial therapy.
• Pre-procedural Hygiene: Patients are advised to bathe or shower before the procedure to minimize skin flora contamination at the puncture site.

During the Procedure

The bone marrow aspiration is performed by a qualified hematologist, oncologist, or trained medical specialist under strict aseptic conditions. The step-by-step clinical process involves:

• Patient Positioning: The patient is typically placed in the prone (lying on the stomach) or lateral decubitus (lying on the side) position to access the posterior superior iliac spine (pelvic bone), which is the most common and safest site for aspiration. In rare clinical scenarios, the sternum may be utilized.
• Aseptic Preparation: The skin overlying the biopsy site is thoroughly cleansed with an antiseptic solution (such as chlorhexidine gluconate or povidone-iodine) and draped with sterile towels.
• Local Anesthesia: The clinician infiltrates the skin, subcutaneous tissue, and the highly sensitive periosteum (bone surface) with a local anesthetic, typically 1% or 2% lidocaine, to ensure patient comfort.
• Aspiration: A specialized bone marrow aspiration needle (such as a Jamshidi needle) is carefully advanced through the outer cortex of the bone into the marrow cavity. Once positioned, a sterile syringe is attached, and approximately 1 to 3 milliliters of liquid bone marrow aspirate is withdrawn. Patients may experience a brief, sharp, pulling sensation during actual aspiration.
• Specimen Inoculation: The obtained aspirate is immediately divided. A portion is inoculated directly into specialized blood culture bottles (aerobic and anaerobic) or sterile heparinized tubes to prevent clotting, while another portion is used to prepare direct smears for cytological and microbiological staining.
• Post-Procedure Care: The needle is removed, and firm pressure is applied to the site for several minutes to achieve hemostasis. A sterile pressure bandage is then applied. The patient is monitored for a brief period before discharge.

When is a Culture & Sensitivity – Bone Marrow (SHM) Performed?

Fever of Unknown Origin (FUO)

Fever of Unknown Origin presents a significant diagnostic challenge to clinicians, defined as a persistent fever exceeding 38.3°C (101°F) on multiple occasions over several weeks without a clear diagnosis despite basic investigations. When initial blood cultures, imaging, and serological tests fail to identify an infectious source, a bone marrow culture is indicated. Because the bone marrow concentrates intracellular pathogens and slow-growing organisms, it frequently yields positive cultures when peripheral blood remains sterile, providing the definitive diagnosis needed to initiate targeted therapy.

Suspected Disseminated Tuberculosis or Mycobacterial Infection

In patients presenting with suspected disseminated tuberculosis (miliary TB) or atypical mycobacterial infections (such as Mycobacterium avium complex), the pathogens often disseminate hematogenously and localize within the reticuloendothelial system of the bone marrow. This is particularly common in immunocompromised individuals, such as those with advanced HIV/AIDS or patients undergoing immunosuppressive therapy. A bone marrow culture provides a highly reliable method for isolating acid-fast bacilli (AFB), allowing for subsequent drug susceptibility testing against first- and second-line anti-tubercular agents.

Diagnosis of Enteric Fever (Typhoid) and Brucellosis

Enteric fever, caused by Salmonella enterica serovars Typhi and Paratyphi, and brucellosis, caused by Brucella species, are endemic in many regions, including Pakistan. While peripheral blood cultures are highly effective during the first week of enteric fever, their sensitivity drops significantly in subsequent weeks or after the administration of empiric antibiotics. Salmonella typhi persists in the bone marrow even after antibiotic treatment has commenced. Therefore, bone marrow culture remains the gold standard for diagnosing enteric fever and chronic brucellosis, offering a significantly higher diagnostic yield than blood cultures in subacute cases.

Evaluation of Visceral Leishmaniasis (Kala-Azar)

Visceral Leishmaniasis is a severe, potentially fatal parasitic disease caused by protozoan parasites of the genus Leishmania, transmitted by the bite of infected sandflies. The parasite targets the reticuloendothelial system, primarily multiplying within the macrophages of the bone marrow, liver, and spleen. While microscopic examination of bone marrow smears can reveal the characteristic Leishman-Donovan (LD) bodies, culturing the bone marrow aspirate in specialized media (such as Novy-MacNeal-Nicolle medium) allows for the isolation and confirmation of the parasite, especially in cases with low parasitic loads.

Systemic Infections in Immunocompromised Patients

Immunocompromised individuals, including patients undergoing active chemotherapy, bone marrow transplant recipients, and those on biological response modifiers, are highly susceptible to opportunistic systemic infections. These infections may be fungal (such as histoplasmosis, cryptococcosis, or disseminated candidiasis) or bacterial. Because these patients often exhibit atypical clinical presentations and suppressed inflammatory responses, a bone marrow culture is a vital diagnostic tool to rapidly identify opportunistic pathogens and direct life-saving antimicrobial or antifungal therapy.

What Does a Culture & Sensitivity – Bone Marrow (SHM) Detect?

The Culture & Sensitivity – Bone Marrow (SHM) test is capable of detecting a wide spectrum of pathogenic microorganisms that cause systemic or localized bone marrow infections. The primary findings and pathogens identified through this comprehensive analysis include:

• Salmonella enterica serovar Typhi: The causative agent of typhoid fever, frequently isolated from bone marrow even after partial antibiotic treatment.
• Salmonella enterica serovar Paratyphi (A, B, or C): Pathogens responsible for paratyphoid fever, presenting similarly to classic enteric fever.
• Brucella melitensis and Brucella abortus: Intracellular bacteria causing brucellosis, characterized by undulant fevers, joint pain, and organomegaly.
• Mycobacterium tuberculosis: The causative agent of tuberculosis, isolated from bone marrow in cases of miliary or disseminated disease.
• Mycobacterium avium-intracellulare Complex (MAC): An opportunistic mycobacterial pathogen frequently causing systemic infections in severely immunocompromised patients.
• Staphylococcus aureus: A pyogenic bacterium capable of causing hematogenous osteomyelitis and bone marrow abscesses, including Methicillin-Resistant Staphylococcus aureus (MRSA).
• Streptococcus pneumoniae: A major bacterial pathogen that can cause systemic bacteremia and secondary marrow infiltration.
• Escherichia coli: A Gram-negative bacillus associated with severe sepsis and hematogenous dissemination to the bone marrow.
• Klebsiella pneumoniae: An opportunistic pathogen capable of causing severe systemic infections and localized bone marrow involvement.
• Pseudomonas aeruginosa: A highly resilient, multi-drug resistant Gram-negative bacterium found in nosocomial infections.
• Acinetobacter baumannii: A problematic nosocomial pathogen often requiring extensive susceptibility testing to identify viable therapeutic options.
• Histoplasma capsulatum: A dimorphic fungus that infects the reticuloendothelial system, frequently detected in bone marrow cultures of patients with disseminated histoplasmosis.
• Cryptococcus neoformans: An encapsulated yeast that can disseminate to the bone marrow, particularly in immunocompromised individuals.
• Candida albicans and non-albicans Candida species: Fungal pathogens responsible for systemic candidiasis and fungemia.
• Aspergillus species: Opportunistic molds that can cause disseminated invasive aspergillosis in severely neutropenic patients.
• Leishmania donovani: The protozoan parasite responsible for visceral leishmaniasis, confirmed via specialized culture.
• Listeria monocytogenes: A Gram-positive rod that can cause systemic infections, particularly in pregnant women, neonates, and immunocompromised hosts.
• Neisseria meningitidis: The causative agent of meningococcemia, which can occasionally be isolated from bone marrow during acute systemic infection.
• Talaromyces marneffei (formerly Penicillium marneffei): An opportunistic dimorphic fungus endemic in Southeast Asia, affecting immunocompromised patients.
• Coccidioides immitis: A fungal pathogen causing coccidioidomycosis, which can disseminate to the bones and marrow.
• Blastomyces dermatitidis: The causative agent of blastomycosis, capable of systemic dissemination.
• Absence of Aerobic Bacterial Growth: A normal finding indicating no aerobic bacterial pathogens were isolated during the standard incubation period.
• Absence of Anaerobic Bacterial Growth: A normal finding indicating no anaerobic bacterial pathogens were isolated.
• Absence of Fungal Growth: A normal finding indicating no fungal elements were recovered after extended incubation.
• Absence of Acid-Fast Bacilli (AFB): A normal finding indicating no mycobacterial growth was observed.
• Antimicrobial Susceptibility Profile (MIC): Quantitative data detailing the minimum inhibitory concentration of various antibiotics against the isolated pathogen, classifying them as Sensitive (S), Intermediate (I), or Resistant (R).

Turnaround Time and Report Access at Dr. Essa Lab

The turnaround time (TAT) for a Culture & Sensitivity – Bone Marrow (SHM) test is inherently dependent on the growth rate of the specific microorganism suspected. Standard aerobic and anaerobic bacterial cultures typically show initial signs of growth within 24 to 48 hours. If growth is detected, preliminary identification and susceptibility testing are initiated, with intermediate reports often available within 3 to 4 days. However, a final negative report for routine bacterial cultures is only issued after 5 to 7 days of continuous monitoring to ensure no slow-growing organisms are missed.

For specialized cultures, the incubation period is significantly longer. Suspected Brucella cultures are maintained for up to 14 to 21 days. Fungal cultures require up to 4 weeks of incubation, and mycobacterial cultures (AFB) may require 6 to 8 weeks to definitively rule out infection. Dr. Essa Lab utilizes automated continuous-monitoring blood culture systems that immediately alert laboratory staff the moment microbial growth is detected, minimizing unnecessary delays.

Patients and referring physicians can conveniently access reports online through the official Dr. Essa Lab web portal or mobile application. Once validated by a Consultant Microbiologist, the digital report is uploaded in real-time. Patients can also receive SMS notifications with direct links to download their secure PDF reports, or they can collect printed copies from any Dr. Essa Lab diagnostic center across Karachi and other major cities.

Culture & Sensitivity – Bone Marrow (SHM) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Aerobic Bacterial Culture	No growth of aerobic bacteria after 5-7 days of incubation.	Isolation of pathogens such as Salmonella typhi, Staphylococcus aureus, or Gram-negative bacilli.
Anaerobic Bacterial Culture	No growth of anaerobic bacteria after standard incubation.	Isolation of anaerobic pathogens (e.g., Bacteroides spp., Clostridium spp.).
Mycobacterial Culture (AFB)	No growth of acid-fast bacilli after 6-8 weeks of incubation.	Isolation of Mycobacterium tuberculosis or atypical mycobacteria (MAC).
Fungal Culture	No fungal growth observed after 4 weeks of incubation.	Isolation of yeasts (e.g., Candida, Cryptococcus) or dimorphic fungi (e.g., Histoplasma).
Parasitic Evaluation (Culture/Smear)	No parasites detected.	Presence of Leishmania donovani amastigotes (LD bodies).
Antimicrobial Susceptibility Testing (AST)	Not applicable (no organism isolated).	Determination of sensitivity, intermediate resistance, or full resistance to specific antimicrobial agents.
Time to Positivity (TTP)	No growth detected within the incubation timeframe.	Rapid growth (short TTP) suggesting high bacterial load; delayed growth suggesting fastidious organisms.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Culture & Sensitivity – Bone Marrow (SHM)?

• Experienced Healthcare Professionals: Dr. Essa Lab employs highly qualified Consultant Pathologists, Microbiologists, and skilled laboratory technologists dedicated to maintaining the highest diagnostic standards.
• Patient-Focused Care: The laboratory prioritizes patient comfort, safety, and clear communication throughout the testing process, ensuring a supportive diagnostic experience.
• Quality Diagnostic Services: Utilizing stringent internal quality control measures and external quality assurance programs, Dr. Essa Lab delivers highly reliable and accurate test results.
• Professional Reporting: All culture and sensitivity reports are thoroughly reviewed and signed off by consultant-level medical specialists to ensure clinical accuracy and relevance.
• Modern Diagnostic Approach: The microbiology department is equipped with advanced automated systems for continuous-monitoring cultures and rapid bacterial identification and susceptibility testing.
• Comfortable Environment: Diagnostic centers are designed to provide a clean, sterile, and comfortable environment for patients undergoing sample submission or clinical procedures.
• Convenient Location: With an extensive network of collection points and diagnostic centers across Karachi and beyond, accessing quality diagnostic services is highly convenient.
• Commitment to Accurate Diagnosis: Dr. Essa Lab has maintained a legacy of diagnostic excellence since 1987, serving as a trusted partner for clinicians and patients in Pakistan.